Gene Therapy Strategies for Lung Cancer: Overcoming Barriers and Demonstrating Therapeutic Utility

Strategic Insights -

Gene therapy has shown promising results in tackling lung cancer, but its systemic delivery can be impaired by various factors. Scientists in Galway, Ireland, have made a breakthrough by utilizing mesenchymal stem cells (MSCs) to carry a tumouricidal gene therapy vector, which can home to tumour sites and induce apoptosis in lung carcinoma cells. The researchers successfully transduced MSCs with an adenoviral vector expressing TRAIL (Ad.TR) and demonstrated its apoptosis-inducing activity on A549 lung carcinoma cells. The study also showed that Ad.TR-transduced MSCs can transfer viral DNA to cocultured A549 cells, resulting in transgenic protein production, even in the presence of human serum containing high levels of adenovirus neutralizing antibodies.

Key Takeaways:

  • MSCs can home to tumour sites and act as a shield and vehicle for tumouricidal gene therapy vectors.
  • The adenoviral vector expressing TRAIL (Ad.TR) can transduce MSCs, leading to apoptosis in A549 lung carcinoma cells.
  • Ad.TR-transduced MSCs can transfer viral DNA to cocultured A549 cells, resulting in transgenic protein production.
  • This transfer is not inhibited by exposure to human serum containing high levels of adenovirus neutralizing antibodies.
  • Ad.TR-transduced MSCs do not induce T-cell proliferation, which may result in cytotoxic T-cell-mediated apoptosis induction in the Ad.TR-transduced MSCs.
  • The study demonstrates the stability of Ad.TR in the context of the blood environment.
  • The researchers conclude that this is the first study to demonstrate the potential therapeutic utility of Ad.TR-transduced MSCs in cancer cells.

Statistics:

  • The study was published in the Journal of Cellular and Molecular Medicine in 2008.
  • The article was prepared by Cancer Gene Therapy Week editors from staff and other reports.
  • The study consisted of a xenograft mouse model using A549 cells.
  • The Ad.TR-transduced MSCs were shown to induce apoptosis in A549 cells in the presence of physiological concentrations of WBC, erythrocytes, and sera from human donors.
  • The study utilized MSCs transduced with Ad.enhanced-green-fluorescent-protein (EGFP) to show transfer of viral DNA to cocultured A549 cells.

Sources:

  • "Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model." Journal of Cellular and Molecular Medicine, 2008;12(6B):2628-2643.
  • Cancer Gene Therapy Week editors, "Gene therapy strategies for lung cancer: overcoming barriers and demonstrating therapeutic utility."
  • National University Ireland, NCBES, Molecular Therapeutic Group, University of Rd., Galway, Ireland.
  • Wiley-Blackwell Publishing, Inc., Commerce Place, 350 Main St., Malden 02148, MA, USA.